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What is already known about this topic? 
• Incidence rate of BCC in the UK is high compared with other types of nonmelanoma 
skin cancers. 
• Risk factors include exposure to UV through sunlight or tanning beds, age and 
ethnicity. 
• Incidence in the younger population is rising, although incidence increases after 40 
years of age.  
•  
What does this study add? 
• These findings provide novel estimates for regional incidence rates across the UK. 
• They provide novel estimates for levels of socioeconomic deprivation in UK. 
 
Corresponding author: Anwar Musah  
Room C109, Division of Epidemiology and Public Health,  
Clinical Sciences Building (Phase 2), Nottingham City Hospital Campus, 
University of Nottingham, Nottingham, NG5 1PB, UK 
Telephone: +44 (0)115 823 1382; 
Email address: mcxam23@nottingham.ac.uk 
 
Abstract 
Background  Basal cell carcinoma (BCC) is one the most common type of nonmelanoma skin 
cancer affecting the Caucasian population; however, little is known about how the incidence 
varies across regions in the UK. 
Methods  Data from 2004 to 2010 was obtained from The Health Improvement Network 
(THIN database). European and World Age-standardised incidence rates (EASRs and 
WASRs, respectively) were obtained for country-level estimates and levels of socioeconomic 
deprivation, whilst Strategic Health Authority-level estimates were directly age-sex 
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standardised to UK standard population. Incidence rate ratios (IRR) were estimated using 
multivariable Poisson regression models. 
Results  The overall EASR and WASR of BCC in the UK was 98.6 per 100,000 person-years 
and 66.9 per 100,000 person-years, respectively. Regional-level incidence rates indicated a 
significant geographical variation in the distribution of BCC, which was more pronounced in 
the southern parts of the country; South East Coast had the highest BCC rate followed by 
South Central, Wales and South West. Incidence rates were substantially higher in the least 
deprived groups and we observed a trend of decreasing incidence with increasing levels of 
deprivation (p < 0.001). Finally, in terms of age groups, the largest annual increase was 
observed among those aged 30 to 49 years. 
Conclusions  BCC is an increasing health problem in the UK; the southern regions of UK and 
those in the least deprived groups had a higher incidence of BCC. Our finding indicates the 
increased incidence of BCC for younger age groups below 49 years. 
 
Basal cell carcinoma (BCC), a form of non-melanoma skin cancer (NMSC) is the most 
common malignant neoplasm found in humans and the incidence is increasing in the US, 
Canada, Australia and most European countries.1–5 Risk factors include exposure to UV 
through sunlight or tanning beds,6–8 advancement of age,9 gender,9,10 skin type (i.e. fair, white 
or freckled skin),9,11–13 history of skin cancer,14 and some environmental and occupational 
factors.15 
The incidence of BCC in the UK is increasing at an unprecedented rate. The overall incidence 
of NMSC is estimated to be well over 100,000 cases per year, with BCC accounting for 75% 
of cases, squamous cell carcinoma (SCC) for 20% and other rare skin cancer types (i.e. 
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Merkel cell carcinoma, Kaposi’s sarcoma and T-cell lymphoma of the skin) for 5%.16 Recent 
studies have shown that whilst the incidence of BCC varies geographically in the UK1,17, 
rapidly increasing incidence has been observed in many areas. For instance, in West 
Glamorgan (Wales) the incidence rate increased by 60% between 1988 and 1998.18 Similarly, 
in England, the incidence of BCC in North Humberside tripled over the 13 year period from 
1978 to 1991.1,19 Scotland and Northern Ireland have lower incidence of BCC relative to 
England and Wales, however, within the past two decades the incidence of BCC among men 
has risen approximately by 16% in Scotland and 18% in Northern Ireland.20,21 The elderly 
population contributes substantially to the disease burden, with risk of BCC increasing after 
40 years of age, however, we are now seeing an increased incidence in younger people and in 
particular those of ≤30 years of age.22  
 
Socioeconomic status and deprivation are also known to modify the risk of BCC. Some 
studies suggest that BCC appears to be more common in those belonging to higher social 
class13,23,24. However such associations are not well understood and the distribution of BCC 
in terms of levels socioeconomic deprivation in the UK population is unknown. 
 
We therefore used data from a UK-wide database of primary care medical records to derive 
contemporary regional breakdowns of the incidence of BCC in UK. We present novel 
incidence rate estimates stratified by level of socioeconomic deprivation in the UK and 
additional analyses examining whether BCC incidence has continued to increase in recent 
years, particularly in the younger age groups. 
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Materials and Methods 
Study design and data source 
We conducted a large population-based study using data from The Health Improvement 
Network (THIN). THIN is a large database comprised of anonymised primary care electronic 
medical records of more than 10 million patients from across all regions of the UK. The 
information contained within THIN includes details on all diagnoses made by or reported to 
the general practitioner, as well as other additional health information relevant to primary 
care. THIN is recognised for its completeness and accuracy of data recording, and has been 
validated for its suitability for use in medical research,25 including specific validation of 
diagnoses of BCC.26 In addition, a range of socio-demographic indicators are available in 
THIN, including quintiles of Townsend Deprivation Index27 in each patient’s postcode of 
residence. 
 
Study population 
The medical histories and deprivation indicators of all adults with a first recorded diagnosis 
of BCC between January 1st, 2004 and December 31st, 2010, were extracted from THIN. 
Subjects diagnosed with Basal cell nevus syndrome (or Gorlin’s syndrome), organoid naevi 
or other genetic syndromes were excluded from the study. Patient ages were categorised into 
10-year bands (18–29, 30–39, 40–49, 50–64, 65–79 and 80+ years). Patients were categorised 
into thirteen regional based (in England) on the Strategic Health Authority (SHA) or 
devolved government administration (Wales, Scotland and Northern Ireland) to which each 
patient’s primary care practice belongs as follows: North East, North West, Yorkshire and 
Humber, East Midlands, West Midlands, East of England, London, South East Coast, South 
This article is protected by copyright. All rights reserved. 
Central, South West, Wales, Scotland and Northern Ireland. This is the only spatially 
referenced data available from the anonymised patient records. 
 
Statistical analysis 
The primary outcome measures were incidence rates (IR) of BCC in the whole UK, in its 
constituent countries and principalities, and each English SHA region. We also estimated the 
incidence of BCC across quintiles of socioeconomic deprivation groups. IRs were calculated 
as the number of patients receiving their first diagnosis of BCC divided by the total number 
of person-years at risk. Diagnoses within the first year of registration with a participating 
primary care practice were excluded as such recordings can relate to prevalent, rather than 
incident, events (being an artefact of back-entry of records from a previous practitioner). 
Second or subsequent diagnoses were also excluded as these are difficult to differentiate from 
recurrences and follow-up consultations in primary care records. Population denominators 
were mid-year (1st July) total numbers of persons registered for at least one year at a primary 
care practice enrolled in THIN. IRs are presented as rates per 100,000 person-years. We 
derived estimates for European and World Age-Standardised incidence Rates (EASRs and 
WASRs, respectively) using the direct standardisation method to allow direct comparisons 
between country-level incidence rates (i.e. UK, England, Scotland, Northern Ireland and 
Wales) with other populations.28 IRs of BCC at a regional level were directly age-sex 
standardised to the UK standard population.29 
Poisson multivariable regression model was used to examine the effects of all factors (i.e. 
calendar year of diagnosis, socioeconomic deprivation and regions) on the incidence of BCC 
adjusted for sex and age groups. Stratified Poisson multivariable analyses were used to 
determine whether associations between all factors and the incidence of BCC were modified 
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by sex, while controlling for age groups. For secondary analyses, we further used stratified 
models by age groups to assess calendar years as a continuous variable in order to determine 
the average change (per year) in incidence of BCC. Incidence rate ratios (IRR) were 
estimated with 95% confidence intervals (CI). All statistical analyses were carried out using 
STATA version 12 (STATA Corporation, College Station, TX, USA). 
 
Results 
There were 38,121 incident cases of BCC were identified from 546 general practices in the 
THIN database. Mean age was 64 years (standard deviation, SD 13 years) with slightly more 
men (52.4%) diagnosed with a BCC.  
 
Incidence rates of BCC at country and regional level 
The crude IR of BCC between 2004 and 2010 in our THIN database was 171.9 per 100,000 
person-years (95% CI: 170.1–173.6). The crude IR of BCC was higher among men (183.1 
per 100,000 person-years; 95% CI: 180.5–185.6) than women (161.0 per 100,000 person-
years; 95% CI: 158.7–163.4) (Table 1). When comparing the overall figures between 2004 
and 2010, we found that there was an increase from 154.0 per 100,000 person-years to 182.0 
per 100,000 person-years. Our Poisson multivariable regression model show that the overall 
significant 16% increase in incidence in 2010 as compared to 2004 (IRR 1.16, 95% CI: 1.11–
1.20), which equates to an average increase of 2.5% per year (95% CI: 1.9% – 3.0%; p for 
trend = 0.001) (Table 2). 
Comparatively, at a country-level, Wales has significantly the highest overall crude rate of 
BCC (IR 196.4, 95% CI: 189.2–203.8) followed by England (IR 178.5, 95% CI: 176.5–
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180.5). We observed the incidences were low in Scotland (IR 128.7, 95% CI: 124.6–133.0) 
and Northern Ireland (IR 131.6, 95% CI: 123.3–140.3) (Table 1), and from the 95% 
confidence intervals, there is no significant difference in the incidence of BCC between 
Scotland and Northern Ireland. 
 
We observed important geographical variations in the distribution of BCC (Figure 1). The 
age-sex standardised incidence rate of BCC in South East Coast, South West, South Central 
and Wales are significantly higher than other regions of the UK (Table 3). Our models show 
that the incidence of BCC were significantly lower in West Midlands (IRR 0.92, 95% CI: 
0.88–0.97), Northern Ireland (IRR 0.92, 95% CI: 0.85–0.98) and Scotland (IRR 0.87, 95% 
CI: 0.83–0.91) than in London (the referent). Conversely, we found that the incidence of 
BCC was significantly higher in South East Coast (IRR 1.28, 95% CI: 1.22–1.34), Wales 
(IRR 1.23, 95% CI: 1.16–1.29), South Central (IRR 1.21, 95% CI: 1.15–1.27), South West 
(IRR 1.15, 95% CI: 1.09–1.21) than in London. Our results show no substantial sex-specific 
difference in the incidence of BCC in any regions.  
 
Trends in BCC over time by age group 
Models were stratified by age groups to determine the effects of calendar years on the 
incidence of BCC. Our results show a small average increase of 0.4% per year in the age 
group of 18–29 years, however, this failed to reach statistical significance (95% CI: -8.0% to 
9.3%; p = 0.91). In particular, the largest average increase in incidence was observed for 
those in 30–39 years (3.9% per year, 95% CI: 0.2% to 7.7%; p = 0.04) and 40–49 (4.0% per 
year, 95% CI: 2.0% to 6.1%; p < 0.001) age groups (Figure 2). 
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Incidence rates by socioeconomic deprivation 
The crude incidence of BCC was significantly highest for those living in areas with the lower 
levels of deprivation, with estimates of 222.5 per 100,000 person-years (95% CI: 218.5–
226.5) and 203.2 per 100,000 person-years (95% CI: 199.1–207.3) for those in the 1st quintile 
(least deprived) and 2nd quintile, respectively (Table 4). We observed that the incidence of 
BCC was lowest for those living in the most deprived areas (IR 110.6, 95% CI: 106.8–114.7). 
Using our models, there appeared to be a linear effect of decreasing incidence of BCC with 
increasing levels of deprivation (p for trend < 0.001). We found that those living in the least 
deprived areas were 50% significantly more likely to have a BCC than those with the highest 
levels of deprivation (IRR 1.50, 95% CI: 1.44–1.56). Our models also show substantial 
difference in magnitude of the incidence of BCC between men and women, where the 
incidence rate was higher in men than in women. 
 
Discussion 
Our results indicate that the incidence rate of BCC is increasing in the general population, in 
particular amongst those aged 30 to 49 years. It shows that Wales and the southern parts of 
England have the highest recorded rates of skin BCC. For socioeconomic deprivation, 
incidence of BCC was consistently higher in the least deprived groups.  Based on our 
estimates (i.e. EASRs), they show that approximately 61,500 new cases of BCC are 
diagnosed annually in the UK population. Previous reports using EASRs have estimated that 
53,000 cases of BCC were reported yearly using a cohort between 1996 and 2003,17 
comparatively; this represents an overall increase of 16% in diagnosis rates in the past 
decade.   
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This study has several strengths; to our knowledge, it uses the largest sample size of incident 
cases of BCC compared to previous research conducted in the UK.13,17–21,23 Due to our large 
sample size means that our findings are unlikely to be due by chance. Also, the data was 
obtained from a national database and prospectively recorded by GPs, thus excluding the 
possibility of recording or recall bias in both our exposure and outcome. The major limitation 
is our inability to account for important factors such as history of sun exposure during 
childhood and adolescence (i.e. frequency of sunburns and overseas holidays),30,31 latitudinal 
position (i.e. proximity to the equator),9,32 settings of occupation (i.e. indoor, mixed or 
outdoor)33 and skin type (i.e. fair, white or freckled skin)13. In addition, we were unable to 
classify adults according to subtypes of BCC (i.e. superficial, nodular or infiltrative). 
 
Our results for country-level incidence rates were consistent with previous studies showing 
escalating rates in England, Northern Ireland, Scotland and Wales.18–21 The most likely 
explanation for the rise in incidence may be linked to previous behaviour with regards to sun 
exposure during childhood or adolescence. Exposure to UV radiation during this stage plays a 
significant role in the future development of BCC. Previous studies have shown that subjects 
to have reported to travel frequently and spend more than 4 or 5 weeks (per year) at the beach 
before the age of 20 years were more likely to have developed the skin malignancy in their 
adulthood.30,31 Although we were unable to account for this factor, history of sun exposure 
through frequent holidays to sunnier places has been a strong predictor for BCC. Another 
likely explanation may be possibly due to UK’s aging population. BCC is highly prevalent in 
the older age groups; in our cohort, the number of cases diagnosed with the skin malignancy 
was consistently high among those aged 50+ years.  
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We found a significant increase among those aged 30–39 and 40–49 years. A previous study 
has shown similar findings, where the annual increase in incidence was estimated to be 
approximately 3.9% and 5.2% for 30–39 and 40–49 years, respectively, although these 
estimates did not reach statistical significance.17 Interestingly, we found an increase among 
those aged 18–29 years is increasing, although our models showed no statistical significance. 
The incidence of BCC in this particular age group have risen to approximately 5.2 per 
100,000 person-year in 2009 (Figure 2), which is consistent with escalating rates observed by 
others.22 
We observed especially high incidence in areas of South East Coast, South Central, South 
West and Wales. Compared to London, we found there were significant increases in the risk 
of developing BCC in these areas. This observation may be linked to several environment 
factors. The most prominent is the latitudinal position of a location.9,32 Areas in proximity to 
the equator, but situated in the temperate zone usually experience prolonged duration of 
sunlight in the summer season. In the UK, the hours of sunshine normally last longer in the 
south than the northern regions of UK, especially during the summer season, the southern 
parts of England and Wales are usually known to receive the greatest hours of annual 
sunshine.34  
 
Our findings for socioeconomic deprivation showed that the incidence was high among the 
least deprived groups, and that the risks for BCC tends to decrease as the level of deprivation 
increased. Our results are consistent with previous studies conducted in the UK and 
Netherlands.13,24 It is interesting to note the wide difference in incidence of BCC between the 
least and most deprived groups which may be an indication that socioeconomic status or 
deprivation is risk factor for BCC. This observation may be linked to higher levels of income 
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for frequent holidays overseas to sunnier places, thereby exposing the skin to sunlight, or 
having available funds for pursuing other lifestyle habits which are risk factors for BCC, for 
instance, the frequent use of tanning beds8–10 or consumption of alcohol.35 Interestingly, we 
also observed that the incidences differ substantially between sexes, perhaps, this may 
possibly be due to differences in behaviour in terms of sun exposure, clothing habits and 
tanning behaviour.13,24 
 
BCC is an increasingly important health problem in the UK, with extremely high levels 
observed in the least deprived groups, and in the southern parts of the UK. Due to the multi-
factorial nature of BCC, further work is warranted to identify causes, as well as, investigate 
the detailed reasons of these findings. Our results demonstrate that the incidence of BCC will 
continue to rise much higher in all age bands if it remains unchecked, which will have a 
significant impact on the workload and costs for health services. Better strategies are required 
to inform the public of the risk factors associated with the skin malignancy, as well as, which 
preventive measures can be implemented to avoid future development of BCC.   
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List of figure legends 
Figure 1: Thematic map showing directly age-sex standardised incidence rates of BCC using 
the UK standard population (THIN database 2004–2010). 
Figure 2: Average change in incidence of BCC in the UK stratified by age groups (THIN 
database 2004–2010). 
 
List of tables 
Table 1: Crude and sex-specific age-standardised incidence rates of Basal cell carcinoma in 
UK and countries, THIN database (2004–2010)  
 Men (n) Women (n) Overall (N) 
United Kingdom    
  Crude 183.1 (19,960) 161.0 (18,161) 171.9 (38,121) 
  EASRa 112.2 88.1 98.6 
  WASRb 74.8 60.7 66.9 
England  
  Crude 189.9 (16,079) 167.5 (14,671) 178.5 (30,750)
  EASR 114.9 91.4 101.5 
  WASR 76.6 63.1 69.0 
Northern Ireland    
  Crude 144.7 (502) 119.3 (439) 131.6 (941) 
  EASR 99.6 67.5 81.6 
  WASR 66.2 45.2 54.6 
Scotland  
  Crude 137.9 (1,904) 119.8 (1,704) 128.7 (3,608)
  EASR 89.3 65.6 75.9 
  WASR 59.1 44.7 51.1 
Wales    
  Crude 208.1 (1,475) 185.0 (1,347) 196.4 (2,822) 
  EASR 128.7 103.1 114.4 
  WASR 86.4 71.3 78.1 
aEASR, European age-standardised rate. 
bWASR, World age-standardised rate. 
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Table 2:  Overall and sex-specific incidence rate ratio (IRR) estimates showing associations between 
incidence of BCC and risk factors. 
  Mena  Womena  Overallb 
  IRR   (95% CI)c  IRR   (95% CI)  IRR   (95% CI) 
Years       
  2004  1  1  1 
  2005  1.07   (1.02 – 1.14)  1.00   (0.94 – 1.06)  1.04   (0.99 – 1.08) 
  2006  1.10   (1.04 – 1.16)  1.07   (1.07 – 1.13)  1.09   (1.04 – 1.13) 
  2007  1.14   (1.08 – 1.21)  1.16   (1.10 – 1.23)  1.15   (1.10 – 1.20) 
  2008  1.16   (1.10 – 1.22)  1.16   (1.10 – 1.23)  1.16   (1.12 – 1.20) 
  2009  1.15   (1.09 – 1.22)  1.13   (1.07 – 1.20)  1.15   (1.10 – 1.19) 
  2010  1.12   (1.06 – 1.18)  1.21   (1.14 – 1.27)  1.16   (1.12 – 1.21) 
       
Annual increase  1.8% (1.1% – 2.5%)  3.2% (2.5% – 4.0%)  2.5% (1.9% – 3.0%) 
  (p for trend)  p = 0.003  p = 0.008  p < 0.001 
       
Socioeconomic 
deprivationd 
      
  5th (Most deprived)  1  1  1 
  4th   1.13   (1.06 – 1.20)  1.01   (0.95 – 1.08)  1.07   (1.02 – 1.12) 
  3rd   1.28   (1.21 – 1.36)  1.13   (1.07 – 1.20)  1.21   (1.16 – 1.26) 
  2nd   1.47   (1.39 – 1.56)  1.26   (1.19 – 1.33)  1.37   (1.31 – 1.43) 
  1st (Least deprived)  1.62   (1.53 – 1.72)  1.36   (1.28 – 1.44)  1.50   (1.44 – 1.56) 
  Unknown  1.22   (1.11 – 1.35)  1.12   (1.01 – 1.23)  1.17   (1.09 – 1.25) 
  (p for trend)  p < 0.001  p < 0.001  p < 0.001 
       
Regions       
  London  1  1  1 
  Scotland  0.91   (0.85 – 0.98)  0.82   (0.76 – 0.88)  0.87   (0.83 – 0.91) 
  Northern Ireland  0.99   (0.89 – 1.10)  0.84   (0.76 – 0.94)  0.92   (0.85 – 0.98) 
  West Midlands  0.93   (0.87 – 1.00)  0.92   (0.85 – 0.99)  0.92   (0.88 – 0.97) 
  North West  0.98   (0.91 – 1.05)  0.93   (0.87 – 1.00)  0.96   (0.91 – 1.01) 
  Yorkshire & Humber  1.04   (0.96 – 1.15)  0.98   (0.89 – 1.08)  1.01   (0.95 – 1.08) 
  East Midlands  1.02   (0.93 – 1.11)  1.02   (0.93 – 1.12)  1.02   (0.96 – 1.09) 
  North East  1.08   (0.97 – 1.19)  1.03   (0.93 – 1.14)  1.05   (0.98 – 1.13) 
  East of England  1.05   (0.98 – 1.13)  1.02   (0.95 – 1.10)  1.04   (0.98 – 1.09) 
  Wales  1.25   (1.17 – 1.35)  1.19   (1.11 – 1.29)  1.23   (1.16 – 1.29) 
  South Central  1.24   (1.16 – 1.32)  1.18   (1.10 – 1.26)  1.21   (1.15 – 1.27) 
  South West  1.19   (1.12 – 1.28)  1.10   (1.03 – 1.18)  1.15   (1.09 – 1.21) 
  South East Coast  1.30   (1.21 – 1.39)  1.27   (1.18 – 1.36)  1.28   (1.22 – 1.34) 
aModels were stratified by sex, includes all covariates and adjusted for age groups: i.e. 18–29, 30–39, 40–49, 
50–64, 65–79 and 80+ years. 
bOverall model includes all covariates and adjusted for sex and age bands: i.e. 18–29, 30–39, 40–49, 50–64, 65–
79 and 80+ years. 
cIRR, incidence rate ratio; CI, 95% confidence interval. 
dQuintiles of Townsend deprivation index. 
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Table 3: Regional-level estimates for sex-specific and age-sex standardised incidence rates of 
Basal cell carcinoma in UK, THIN database (2004–2010) 
 Age-sex standardised ratea Sex-specific age standardised rateb 
Regions Overall (N) Men (n) Women (n) 
Scotland 127.9 139.5 (1,904) 116.8 (1,704)
Northern Ireland 138.4 155.4 (502) 122.2 (439) 
London 144.0 148.6 (1,432) 139.6 (1,415)
West Midlands 144.1 152.2 (1,537) 136.3 (1,422) 
North West 146.5 156.6 (1,785) 136.8 (1,627) 
Yorkshire & Humber 151.4 163.3 (686) 140.0 (618) 
North East 156.0 165.2 (539) 147.2 (503) 
East Midlands 158.6 166.4 (776) 151.2 (718) 
East of England 161.1  170.7 (1,457) 151.8 (1,325) 
South West 180.2 196.2 (2,438) 165.0 (2,123)
Wales 185.7 197.6 (1,475) 174.4 (1,347)
South Central 193.5 208.7 (2,998) 178.9 (2,645)
South East Coast 202.7 215.0 (2,431) 191.0 (2,275)
aEstimates are directly age-sex standardised using UK as the standard population.
bSex-specific estimates are directly age-standardised using the UK as the standard population. 
 
 
 
 
Table 4: Crude and sex-specific age-standardised incidence rates of Basal cell carcinoma in 
the UK, by quintiles of Townsend deprivation index (THIN database 2004–2010)  
(a) Deprivation 
index 
1 2 3 4 5 Unknown 
Overall       
  Crude 222.5 
(12,070) 
203.2 
(9,575) 
162.1 
(7,175) 
131.7 
(5,173) 
110.7 
(3,013) 
115.6 
(1,115) 
  EASRa 120.2 106.9 92.2 79.4 70.6 – 
  WASRb 82.1 72.7 62.4 53.5 47.2 – 
Men       
  Crude 246.7 
(6,602) 
220.8 
(5,097) 
169.7 
(3,677) 
134.3 
(2,583) 
106.0 
(1,441) 
119.0 
(560) 
  EASR 137.5 122.0 104.7 90.4 77.4 –
  WASR 92.3 81.5 69.6 59.7 50.9 –
Women       
  Crude 198.9 
(5,468) 
186.2 
(4,478) 
154.7 
(3,498) 
129.2 
(2,590) 
115.3 
(1,572) 
112.4 
(555) 
  EASR 105.7 94.9 83.1 71.9 66.2 – 
  WASR 73.2 65.7 57.1 49.2 44.7 – 
aEASR, European age-standardised rate. 
bWASR, World age-standardised rate. 
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